Rua Bioscience is trading 12% up at NZD 0.03; the available information does not establish a specific reason for the move.

  • A report dated October 6 covered a UK sales and distribution agreement expected to generate more than NZ$10 million over two years; the evidence does not show it caused the gain.
  • The supplied biotechnology-sector context was negative, not aligned with Rua Bioscience’s gain.